Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Active Ingredient Golumumab, Atc L04Ab06 For The Time 01.07.2025 - 30.06.2027
Deadline - May 05, 2027
GT reference number - 109239914
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 109239914
Document Type - Tender Notices
Description - Description: Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to include framework discount contracts for the drugs to be issued at the expense of the statutory health insurance companies. With regard to the relevant legal regulations on the awarding of public orders, a regular process of active ingredient, formal award procedures takes place according to the regulations of the 4th part of the GWB through DAK health. For medicines to be named by the bidder in Appendix 2 to the contract to the above. Active ingredient GOLMUMAB, ATC L04AB06, intends to conclude DAK health until the entry into force of new pharmaceutical discount contracts with all
Gt Ref Id - 109239914
Deadline - May 05, 2027
Similar Tenders :
|
Summary:
|
Join to access thousands of business opportunities
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database
